Strattera

• Other medicines:
• Wellbutrin
• Lexapro
• Celexa
• Anafranil
• Buspar

Strattera (Atomoxetine)

In the United States, the antidepressant Atomoxetine (Strattera) was approved several years ago after extensive controlled studies for the treatment of ADHD in children, young people and adults. Atomoxetine is not a psycho boosters, but a so-called selective norepinephrine reuptake inhibitor (SNRI). Mainly norepinephrine is influenced as the neurotransmitter by taking the medication, however in the medium term of interactions also the dopaminergic system.

Following approval in December 2004, Strattera (Atomoxetine) is available now in March 2005 in Germany. The admission but limited to children and young people. Admission for adults is sought but surely.
The effect of Atomoxetine is only after a few days to weeks expect the setting on the medication can be far from easy.

While the drug essentially thus points would like to make that Atomoxetine is not A psycho boosters and so not on BTM recipes has to be prescribed, the actual benefits of Atomoxetine but probably rather lie

With regard to the treatment of children and adolescents are in principle similar precautions such as the serotonin Wiederaufnahmehemmern. In addition a rote-hand-letter of the manufacturer is available since September 2005, in which a significantly increased risk of favouring or initiation of aggressive behavior, suicidality, and suicide actions under Atomoxetine compared to placebo in children, but not in adults is informed.[3] In the event of suicidal thoughts among the drug to stop taking. During the Atomoxetine application is to look carefully for signs of suicidality. Liver damage have occurred and have led to warnings by the manufacturer.

The current urgent variation is Prof. Dr. Reinhard Kurth according to the head of the BfArM, "necessary.", because after evaluating several latest studies, the number of children, where such changes have occurred, was higher in children treated with Atomoxetine than in peer groups, where a false drug (placebo) was administered "Then is assumed for the referred to changes in the behaviour of children while a rare side effect, whose Häufigkeit is but roughly doubled as compared to a placebo treatment." Comparable studies in adults have shown no increase in risk. The new information also result from a few anecdotal reports have been registered in the EU. The BfArM, so Kurth, "along with the other regulatory authorities the incoming safety evaluation of Atomoxetine continue".

The BfArM recommends parents or carers of children with ADHD and Strattera treatment quickly to inform doctors about such changes in behaviour and, if necessary, seek advice for further treatment.

Source: Federal Institute for drugs and medical devices

Strattera

Hi, years Strattera since 4-5 takes to my brother. If he does they mostly all Okey is and if he will not take them, then he is like a rolling time bomb. This behavior makes me cares…
Strattera 2 x not taken, what happens?

Hello together... when the Dad on holiday is my son... unfortunately I had there not sufficient Strattera, so I have brought new and have... sent by post at the doctor According to the Papa are
My child and Strattera

What age should be given to Stratter and there are also other possibilities for the treatment of ADHD. She herself often said it was evil and always tired, was sometimes turned up and restless...

Methylphenidate: Active ingredient and others of the drug of Ritalins. Methylphenidate belongs to the Group of psychostimulants. According to Müller, Candrian, and Kroptov (2011), methylphenidate inhibits the dopamine amine recovery at the synapses in the striatum. There is therefore an enrichment of amins of dopamine into the synaptic cleft. Still, it stimulates dopamine amine receptors and Noradrenalin receptors of neurons that receive the signal in the event of a frontal brain.

Atomoxetine: Active ingredient of the drug Strattera. Belongs to the Group of sympathomimetic drugs. Inhibits päsynaptischen norepinephrine transporting, which there is an increased concentration of noradrenaline and dopamine in the prefrontal cortex.

ADHD - says Professor Gerd Lehmkuhl, Director of the clinic for child and adolescent psychiatry of the University of Cologne - is inherited, studies show that, during pregnancy, smoking mothers have more hyperactive children, but also education plays a role: the children lack often clear limits and emotional care. As an alternative to medication therapy with Ritalin, the drug Strattera on the market is since March 2005.

Strattera works differently than the stimulants. It is a noradrenarge substance, as a norepinephrine reuptake inhibitor, in this respect it is similar to substances used in depressive disorders.

The drug dampens the hyperactive phase of the children, besides, it has a beneficial effect on the depressive symptoms often could be observed.

Persistent — lasting at least 14 days - according to the current definition down harmonization characterized by loss of pleasure and interest.

Says Jürgen Fritze, Professor of Psychiatry at the University of Frankfurt am Main. Now doctors observe when treated with antidepressants - in this group Strattera falls at least partly - that many patients suffering from suicide thoughts. Reason: Antidepressants cause an inner restlessness...

Statistically dangerous side-effects occur when taking Strattera Hörstürze, heart and suicidal thoughts only for 0.4% of the treated children and young people. But that means that since the launch of the drug in a total 234 cases was the presence of dangerous side effects.

It should already be come in connection with Strattera, according to authorities, four deaths in children and adolescents.

The patient representative in the joint Federal Committee of doctors and health insurance, Jörg Schaaber, considers it very questionable in Germany often in fact healthy children who are just zappelig to treat with so high-risk drug.

Dose

The daily dose Atomoxetine (Strattera ®) can be taken as a single dose in the morning with or without food.

Dosing in children and young people up to 70 kg body weight: treatment with Atomoxetine (Strattera ®) should be initiated with a total daily dose of approximately 0.5 mg / kg. This initial dose should be maintained for at least 7 days before the dose according to the clinical efficacy and tolerability is titriert. The recommended daily dose during the duration of treatment is about 1.2 mg / kg.

Dosing in children and adolescents about 70 kg body weight: treatment with Atomoxetine (Strattera ®) should be started with a total daily dose of 40 mg. This initial dose should be maintained for at least 7 days before the dose according to the clinical efficacy and tolerability is titriert. The recommended maintenance dose is 80 mg daily (information).